DUBLIN, March 31, 2025 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will participate in a fireside chat at the Jones Healthcare and Technology Innovation Conference in Las Vegas on ...

BOSTON, April 14, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and ...

RedHill Biopharma (RDHL) announced that the Company received a written notification from the Listing Qualifications Department of the Nasdaq Stock Market dated April 15, notifying the Company that ...

The Notification Letter has no immediate effect on the Company's listing on the Nasdaq Capital Market at this time, nor are the Company's business operations affected by receipt of the ...

Q1 biopharma layoff trends, plus expectations for Q2 By Ayla Ellison, Gabrielle Masson, Andrea Park Apr 11, 2025 9:25am The Top Line layoffs Cell & Gene Therapy biopharma industry ...

Life sciences and biopharma companies continue to be hurt by concerns that the Trump administration, with Robert F. Kennedy Jr. heading Health and Human Services, could upend everything from ...

TORONTO (AP) — TORONTO (AP) — COSCIENS Biopharma Inc. (CSCI) on Wednesday reported a loss of $6.7 million in its fourth quarter. The Toronto-based company said it had a loss of $2.15 per share.

INGELHEIM, Germany and BOSTON, April 14, 2025 (GLOBE NEWSWIRE) -- Boehringer Ingelheim and Cue Biopharma, Inc. (Nasdaq: CUE) today announced a strategic research collaboration and license ...

NIBRT’s annual Careers in Biopharma event was an ideal opportunity to talk with the industry's key players about the skills they look for in recruits. The biopharma sector is an exciting ...

We came across a bullish thesis on Mereo BioPharma Group plc (MREO) on Substack by Jake LaMotta. In this article, we will summarize the bulls’ thesis on MREO. Mereo BioPharma Group plc (MREO ...